Table 3.
Reference | Number of participants | Age range in years or mean age ± SD |
---|---|---|
Serotonergic and dopaminergic neuromodulation during aging | ||
Antonini et al.48 | 32 | 21–68 |
Erixon-Lindroth et al.44 | 12 | 34–81 |
Costes et al.38 | 53 | 19–70 |
Hesse et al.39 | 22 | 18–83 |
Inoue et al.37 | 27 | 21–82 |
Kaasinen & Rinne49 | 24 | 19–72 |
Kuikka et al.40 | 19 | 22–74 |
Moeller et al.51 | 19 | 23–73 |
Mozley et al.45 | 66 | 41.1 |
Newberg et al.41 | 13 | 22–56 |
Pirker et al.42 | 16 | 21–60 |
Suhara et al.46 | 17 | 20–72 |
Wang et al.47 | 21 | 22–74 |
Wong et al.35 | 44 | 19–76 |
Yamamoto et al.43 | 28 | 20–79 |
Learning and decision making during aging | ||
Denburg et al.118 | 80 | 26–55; 56–85 |
Dreher et al.72 | 13 | 66 ± 5 |
20 | 25 ± 3.7 | |
Eppinger et al.67 | 18 | 20.8 |
18 | 68.5 | |
Eppinger et al.68 | 17 | 10–12 |
18 | 19–24 | |
Frank & Kong111 | 44 | 60–83 |
Hämmerer et al.66 | 44 | 10–12 |
45 | 13–14 | |
46 | 20–30 | |
44 | 65–75 | |
Mell et al.73 | 14 | 26.48 ± 3.96 |
14 | 67.82 ± 5.01 | |
Pietschmann et al.69 | 18 | 23.7 |
25 | 66.1 | |
Samanez–Larkin et al.115 | 12 | 19–27 |
12 | 65–81 | |
Schott et al.71 | 19 | 62–78 |
18 | 19–28 | |
Simon et al.112 | 17 | 18.9 |
24 | 70.3 | |
Weiler et al.100 | 30 | 19–33 |
30 | 50–71 | |
Wood et al.117 | 88 | 18–34 |
67 | 65–88 |